ESC 365
Menu
Home
Search
Events
About
ESC Platforms
Escardio.org
ESC 365
ESC eLearning
Create an account
Sign in
Back
Open Access
Q&A - Paradigm shifts in HFrEF management: SGLT2-Inhibitors.
Session:
Paradigm shifts in HFrEF management: SGLT2-Inhibitors
Topic:
Chronic Heart Failure
Speaker:
Professor C. Chiang (Taipei, TW)
Associate Professor J. Tan (Singapore, SG)
Sponsored by AstraZeneca
Event:
ESC Asia with APSC & AFC 2020
Congress Presentation
Sign in to view the resources
About the speakers
Professor Chern-En Chiang
Taipei Veterans General Hospital, Taipei (Taiwan)
1
presentation
0
follower
Associate Professor Jack Wei Chieh Tan
National Heart Centre Singapore, Singapore (Singapore)
13
presentations
2
followers
1
more
presentation
in this session
Paradigm shifts in HFrEF management: SGLT2-Inhibitors.
Access
Video
Access the full session
Paradigm shifts in HFrEF management: SGLT2-Inhibitors
Speakers:
Professor C. Chiang, Associate Professor J. Tan
Access
Video
About the event
ESC Asia with APSC & AFC 2020
3 December - 5 December 2020
Sessions
Presentations
ESC 365 is supported by
Explore sponsored resources